Annual CFF
$19.80 M
+$12.58 M+174.40%
31 December 2023
Summary:
Pieris Pharmaceuticals annual cash flow from financing activities is currently $19.80 million, with the most recent change of +$12.58 million (+174.40%) on 31 December 2023. During the last 3 years, it has risen by +$9.68 million (+95.70%). PIRS annual CFF is now -66.52% below its all-time high of $59.13 million, reached on 31 December 2021.PIRS Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
$0.00
$0.000.00%
30 September 2024
Summary:
Pieris Pharmaceuticals quarterly cash flow from financing activities is currently $0.00, unchanged on 30 September 2024. Over the past year, it has stayed the same.PIRS quarterly CFF is now -100.00% below its all-time high of $48.16 million, reached on 31 March 2018.PIRS Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$14.00 K
$0.000.00%
30 September 2024
Summary:
Pieris Pharmaceuticals TTM cash flow from financing activities is currently $14.00 thousand, unchanged on 30 September 2024. Over the past year, it has dropped by -$19.86 million (-99.93%). PIRS TTM CFF is now -99.98% below its all-time high of $59.13 million, reached on 31 December 2021.PIRS TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PIRS Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +174.4% | 0.0% | -99.9% |
| 3 y3 years | +95.7% | -100.0% | -100.0% |
| 5 y5 years | -59.2% | -100.0% | -97.2% |
PIRS Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -66.5% | +174.4% | -100.0% | -100.0% | at low | |
| 5 y | 5 years | -66.5% | +174.4% | -100.0% | -100.0% | at low | |
| alltime | all time | -66.5% | >+9999.0% | -100.0% | +100.0% | -100.0% | +101.2% |
Pieris Pharmaceuticals Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $0.00(0.0%) | $14.00 K(0.0%) |
| June 2024 | - | $0.00(-100.0%) | $14.00 K(-99.9%) |
| Dec 2023 | $19.80 M(+174.4%) | $14.00 K(>+9900.0%) | $19.80 M(-0.4%) |
| Sept 2023 | - | $0.00(-100.0%) | $19.87 M(-1.4%) |
| June 2023 | - | $19.78 M(>+9900.0%) | $20.16 M(+179.4%) |
| Dec 2022 | $7.21 M(-87.8%) | $93.00 K(-67.0%) | $7.21 M(-40.0%) |
| Sept 2022 | - | $282.00 K(+0.4%) | $12.02 M(-64.3%) |
| June 2022 | - | $281.00 K(-95.7%) | $33.66 M(-39.9%) |
| Mar 2022 | - | $6.56 M(+33.8%) | $55.99 M(-5.3%) |
| Dec 2021 | $59.13 M(+484.5%) | $4.90 M(-77.6%) | $59.13 M(+8.9%) |
| Sept 2021 | - | $21.92 M(-3.1%) | $54.30 M(+29.3%) |
| June 2021 | - | $22.62 M(+133.3%) | $42.01 M(+112.1%) |
| Mar 2021 | - | $9.69 M(>+9900.0%) | $19.81 M(+95.8%) |
| Dec 2020 | $10.12 M(-68.6%) | $75.00 K(-99.2%) | $10.12 M(-75.7%) |
| Sept 2020 | - | $9.62 M(+2213.5%) | $41.70 M(+29.1%) |
| June 2020 | - | $416.00 K(>+9900.0%) | $32.30 M(+0.4%) |
| Mar 2020 | - | $0.00(-100.0%) | $32.17 M(0.0%) |
| Dec 2019 | $32.17 M(-33.7%) | $31.66 M(>+9900.0%) | $32.17 M(+6231.9%) |
| Sept 2019 | - | $221.00 K(-21.1%) | $508.00 K(-9.8%) |
| June 2019 | - | $280.00 K(>+9900.0%) | $563.00 K(+59.9%) |
| Mar 2019 | - | $0.00(-100.0%) | $352.00 K(-99.3%) |
| Dec 2018 | $48.51 M | $7000.00(-97.5%) | $48.51 M(-1.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2018 | - | $276.00 K(+300.0%) | $49.10 M(-3.4%) |
| June 2018 | - | $69.00 K(-99.9%) | $50.85 M(-2.7%) |
| Mar 2018 | - | $48.16 M(+7966.8%) | $52.25 M(+1177.5%) |
| Dec 2017 | $4.09 M(-73.1%) | $597.00 K(-70.6%) | $4.09 M(+17.1%) |
| Sept 2017 | - | $2.03 M(+38.4%) | $3.49 M(+148.6%) |
| June 2017 | - | $1.47 M(>+9900.0%) | $1.41 M(-90.8%) |
| Dec 2016 | $15.22 M(-38.2%) | $0.00(-100.0%) | $15.22 M(-0.1%) |
| Sept 2016 | - | -$59.70 K(-100.4%) | $15.23 M(-62.9%) |
| June 2016 | - | $15.28 M(>+9900.0%) | $41.07 M(+59.5%) |
| Mar 2016 | - | $0.00(-100.0%) | $25.74 M(+4.6%) |
| Dec 2015 | $24.62 M(+21.1%) | $10.00 K(-100.0%) | $24.62 M(+0.0%) |
| Sept 2015 | - | $25.78 M(<-9900.0%) | $24.61 M(-2206.3%) |
| June 2015 | - | -$43.40 K(-96.2%) | -$1.17 M(+5.6%) |
| Mar 2015 | - | -$1.13 M(<-9900.0%) | -$1.11 M(-4707.5%) |
| Dec 2014 | $20.33 M(>+9900.0%) | - | - |
| Sept 2014 | - | $3000.00(-84.2%) | $24.00 K(+14.3%) |
| June 2014 | - | $19.00 K(+4650.0%) | $21.00 K(+950.0%) |
| June 2014 | $21.00 K(-93.6%) | - | - |
| Mar 2014 | - | $400.00(-75.0%) | $2000.00(+25.0%) |
| Dec 2013 | $327.20 K(+5849.1%) | $1600.00(>+9900.0%) | $1600.00(>+9900.0%) |
| Sept 2013 | - | $0.00 | $0.00 |
| June 2013 | $5500.00 | - | - |
FAQ
- What is Pieris Pharmaceuticals annual cash flow from financing activities?
- What is the all time high annual CFF for Pieris Pharmaceuticals?
- What is Pieris Pharmaceuticals annual CFF year-on-year change?
- What is Pieris Pharmaceuticals quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Pieris Pharmaceuticals?
- What is Pieris Pharmaceuticals quarterly CFF year-on-year change?
- What is Pieris Pharmaceuticals TTM cash flow from financing activities?
- What is the all time high TTM CFF for Pieris Pharmaceuticals?
- What is Pieris Pharmaceuticals TTM CFF year-on-year change?
What is Pieris Pharmaceuticals annual cash flow from financing activities?
The current annual CFF of PIRS is $19.80 M
What is the all time high annual CFF for Pieris Pharmaceuticals?
Pieris Pharmaceuticals all-time high annual cash flow from financing activities is $59.13 M
What is Pieris Pharmaceuticals annual CFF year-on-year change?
Over the past year, PIRS annual cash flow from financing activities has changed by +$12.58 M (+174.40%)
What is Pieris Pharmaceuticals quarterly cash flow from financing activities?
The current quarterly CFF of PIRS is $0.00
What is the all time high quarterly CFF for Pieris Pharmaceuticals?
Pieris Pharmaceuticals all-time high quarterly cash flow from financing activities is $48.16 M
What is Pieris Pharmaceuticals quarterly CFF year-on-year change?
Over the past year, PIRS quarterly cash flow from financing activities has changed by $0.00 (0.00%)
What is Pieris Pharmaceuticals TTM cash flow from financing activities?
The current TTM CFF of PIRS is $14.00 K
What is the all time high TTM CFF for Pieris Pharmaceuticals?
Pieris Pharmaceuticals all-time high TTM cash flow from financing activities is $59.13 M
What is Pieris Pharmaceuticals TTM CFF year-on-year change?
Over the past year, PIRS TTM cash flow from financing activities has changed by -$19.86 M (-99.93%)